OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adherence to treatment, a challenge even in treatable metabolic rare diseases: A cross sectional study of Wilson's disease
Elodie Jacquelet, Aurélia Poujois, Marie‐Christine Pheulpin, et al.
Journal of Inherited Metabolic Disease (2021) Vol. 44, Iss. 6, pp. 1481-1488
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Current and Emerging Issues in Wilson’s Disease
Eve A. Roberts, Michael L. Schilsky
New England Journal of Medicine (2023) Vol. 389, Iss. 10, pp. 922-938
Closed Access | Times Cited: 39

EASL-ERN Clinical Practice Guidelines on Wilson’s disease
Piotr Socha, Wojciech Jańczyk, Alberto Zanetto, et al.
Journal of Hepatology (2025) Vol. 82, Iss. 4, pp. 690-728
Closed Access | Times Cited: 1

The Role of Zinc in the Treatment of Wilson’s Disease
Abolfazl Avan, Anna Członkowska, Susan Gaskin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9316-9316
Open Access | Times Cited: 25

Neurological worsening in Wilson disease – clinical classification and outcome
Isabelle Mohr, Jan Pfeiffenberger, Ecem Eker, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 321-328
Closed Access | Times Cited: 14

Barriers and facilitators to the implementation of guidelines in rare diseases: a systematic review
Matthew Gittus, Jiehan Chong, Anthea Sutton, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 12

Benefits of using exchangeable copper and the ratio of exchangeable copper in a real‐world cohort of patients with Wilson disease
Zoe Mariñó, Cristina Molera Busoms, Célia Bádenas, et al.
Journal of Inherited Metabolic Disease (2023) Vol. 46, Iss. 5, pp. 982-991
Open Access | Times Cited: 11

Adherence to medical treatment for Wilson’s disease in children and adolescents: a cohort study from Turkey
Mehmet Akif Göktaş, Nadir Yalçın
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4

Liver transplantation for Wilson disease: Current knowledge and future perspectives
Alberto Ferrarese, Nora Cazzagon, Patrizia Burra
Liver Transplantation (2024) Vol. 30, Iss. 12, pp. 1289-1303
Closed Access | Times Cited: 4

A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment?
Isabelle Mohr, Patrick Lamade, Christophe Weber, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access

N,N’bis-(2-mercaptoethyl) isophthalamide (NBMI) as a novel chelator for Wilson’s Disease
Rajitha Gadde, Shrey Shah, Mark Böhlke, et al.
Free Radical Biology and Medicine (2025)
Closed Access

Performance of Relative Exchangeable Copper for the Diagnosis of Wilson Disease in Acute Liver Failure
Daniela Spirea, Claire Vanlemmens, François Parant, et al.
Journal of Inherited Metabolic Disease (2025) Vol. 48, Iss. 2
Open Access

Non-ceruloplasmin copper and urinary copper in clinically stable Wilson Disease: Alignment with recommended targets
Peter Ott, Thomas Damgaard Sandahl, Aftab Ala, et al.
JHEP Reports (2024) Vol. 6, Iss. 8, pp. 101115-101115
Open Access | Times Cited: 3

Accurate non-ceruloplasmin bound copper: a new biomarker for the assessment and monitoring of Wilson disease patients using HPLC coupled to ICP-MS/MS
Chris F. Harrington, Geoff Carpenter, James P. C. Coverdale, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 63, Iss. 2, pp. 320-328
Closed Access | Times Cited: 3

Long-Term Urinary Copper Excretion and Exchangeable Copper in Children With Wilson Disease Under Chelation Therapy
Dany Hermann Ngwanou, Eduardo Couchonnal, François Parant, et al.
Journal of Pediatric Gastroenterology and Nutrition (2022) Vol. 75, Iss. 4, pp. e75-e80
Closed Access | Times Cited: 14

Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the national health insurance database
Thomas Daniel-Robin, Bernard Bénichou, Claire Leboucher, et al.
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 46, Iss. 10, pp. 101992-101992
Closed Access | Times Cited: 12

Diagnosis and Outcomes of Late‐Onset Wilson's Disease: A National Registry‐Based Study
Christelle Nilles, Mickaël Alexandre Obadia, Rodolphe Sobesky, et al.
Movement Disorders (2022) Vol. 38, Iss. 2, pp. 321-332
Open Access | Times Cited: 12

Trientine Tetrahydrochloride, From Bench to Bedside: A Narrative Review
C. Omar F. Kamlin, Timothy Jenkins, Jamie Heise, et al.
Drugs (2024)
Open Access | Times Cited: 2

Self-Reported Medication Adherence Measured with Morisky Scales in Rare Disease Patients: A Systematic Review and Meta-Analysis
Ana María García-Muñoz, Desirée Victoria-Montesinos, Begoña Cerdá, et al.
Healthcare (2023) Vol. 11, Iss. 11, pp. 1609-1609
Open Access | Times Cited: 5

Medication adherence among patients with cardiovascular diseases: a cross-sectional study
Maha Subih, Fadwa Abu Saleh, Malakeh Z. Malak
Journal of research in nursing (2023) Vol. 28, Iss. 4, pp. 272-282
Closed Access | Times Cited: 5

Clinical and Genetic Analysis in Neurological Wilson’s Disease Patients With Neurological Worsening Following Chelator Therapy
Haiman Hou, Dingbang Chen, Junxiu Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 8

Editorial: Tracking the course of Wilson's disease
Maryam Moini, Eve A. Roberts
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 6, pp. 811-812
Closed Access | Times Cited: 1

Practical and Multidisciplinary Review on Wilson Disease: The Portuguese Perspective
Filipe Calinas, Hélder Cardoso, Sofia Carvalhana, et al.
GE Portuguese Journal of Gastroenterology (2024), pp. 1-17
Open Access | Times Cited: 1

Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests
Olivier Guillaud, Jérôme Dumortier, Eduardo Couchonnal‐Bedoya, et al.
Diagnostics (2023) Vol. 13, Iss. 2, pp. 256-256
Open Access | Times Cited: 3

Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study
Zoe Mariñó, Marina Berenguer, Luis Peña Quintana, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4823-4823
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top